Verition Fund Management LLC Myriad Genetics Inc Transaction History
Verition Fund Management LLC
- $17.4 Billion
- Q3 2024
A detailed history of Verition Fund Management LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 88,903 shares of MYGN stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
88,903
Previous 8,492
946.9%
Holding current value
$1.11 Million
Previous $207,000
1075.36%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MYGN
# of Institutions
250Shares Held
90.6MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$189 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$129 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$84 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$64.7 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$58.8 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.01B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...